Summary
PreOmics GmbH is a spin-off of the Max-Planck Institute of Biochemistry founded in 2016. We are currently developing iSTantibody, a novel product for the seamless preparation of therapeutic monoclonal antibodies (mAbs) and host cell proteins (HCPs) prior to Mass Spectrometry...
More information & hyperlinks
Web resources: | http://www.preomics.com |